GEODE CAPITAL MANAGEMENT, LLC - MOLECULIN BIOTECH INC ownership

MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D200. A total of 27 filers reported holding MOLECULIN BIOTECH INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of MOLECULIN BIOTECH INC
ValueSharesWeighting
Q3 2023$105,484
-26.1%
246,670
+0.1%
0.00%
Q2 2023$142,645
-39.7%
246,4510.0%0.00%
Q1 2023$236,592
+90548.3%
246,4510.0%0.00%
Q4 2022$261
-99.9%
246,451
-0.2%
0.00%
Q3 2022$261,000
-27.1%
247,0510.0%0.00%
Q2 2022$358,000
-18.1%
247,051
+0.6%
0.00%
Q1 2022$437,000
-4.2%
245,6120.0%0.00%
Q4 2021$456,000
-38.0%
245,6120.0%0.00%
Q3 2021$736,000
-15.5%
245,612
+3.4%
0.00%
Q2 2021$871,000
+22.2%
237,586
+35.9%
0.00%
Q1 2021$713,000174,8220.00%
Other shareholders
MOLECULIN BIOTECH INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,040,529$1,852,0000.61%
Sigma Planning Corp 57,500$102,0000.00%
OSAIC HOLDINGS, INC. 4,233$7,0000.00%
BANK OF AMERICA CORP /DE/ 6,650$12,0000.00%
WELLS FARGO & COMPANY/MN 4,176$7,0000.00%
NORTHERN TRUST CORP 50,731$90,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 245,612$437,0000.00%
STATE STREET CORP 71,397$127,0000.00%
North Star Investment Management Corp. 250$00.00%
View complete list of MOLECULIN BIOTECH INC shareholders